BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17570542)

  • 1. Alien inhibits E2F1 gene expression and cell proliferation.
    Tenbaum SP; Papaioannou M; Reeb CA; Goeman F; Escher N; Kob R; von Eggeling F; Melle C; Baniahmad A
    Biochim Biophys Acta; 2007 Sep; 1773(9):1447-54. PubMed ID: 17570542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic involvement of Alien/ESET complex in thyroid hormone-mediated repression of E2F1 gene expression and cell proliferation.
    Hong W; Li J; Wang B; Chen L; Niu W; Yao Z; Baniahmad A
    Biochem Biophys Res Commun; 2011 Dec; 415(4):650-5. PubMed ID: 22079090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
    Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
    Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the G1/S transition phase in mesangial cells by E2F1.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Oct; 56(4):1238-41. PubMed ID: 10504464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. E2Fs link the control of G1/S and G2/M transcription.
    Zhu W; Giangrande PH; Nevins JR
    EMBO J; 2004 Nov; 23(23):4615-26. PubMed ID: 15510213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
    Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
    Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase.
    Seguin L; Liot C; Mzali R; Harada R; Siret A; Nepveu A; Bertoglio J
    Mol Cell Biol; 2009 Jan; 29(2):570-81. PubMed ID: 19015243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of human chromatin assembly factor ASF1.
    Hayashi R; Goto Y; Tanaka R; Oonogi K; Hisasue M; Yoshida K
    DNA Cell Biol; 2007 Feb; 26(2):91-9. PubMed ID: 17328667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
    Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Api5 contributes to E2F1 control of the G1/S cell cycle phase transition.
    Garcia-Jove Navarro M; Basset C; Arcondéguy T; Touriol C; Perez G; Prats H; Lacazette E
    PLoS One; 2013; 8(8):e71443. PubMed ID: 23940755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.
    Noy-Lotan S; Dgany O; Lahmi R; Marcoux N; Krasnov T; Yissachar N; Ginsberg D; Motro B; Resnitzky P; Yaniv I; Kupfer GM; Tamary H
    Haematologica; 2009 May; 94(5):629-37. PubMed ID: 19336738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
    Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
    Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional coregulator RIP140 represses E2F1 activity and discriminates breast cancer subtypes.
    Docquier A; Harmand PO; Fritsch S; Chanrion M; Darbon JM; Cavaillès V
    Clin Cancer Res; 2010 Jun; 16(11):2959-70. PubMed ID: 20410059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K; Nakajima Y; Eto K; Ikeda MA
    Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid phenethyl ester induces E2F-1-mediated growth inhibition and cell-cycle arrest in human cervical cancer cells.
    Hsu TH; Chu CC; Hung MW; Lee HJ; Hsu HJ; Chang TC
    FEBS J; 2013 Jun; 280(11):2581-93. PubMed ID: 23497083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
    Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
    Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prohibitin interacts with RNF2 and regulates E2F1 function via dual pathways.
    Choi D; Lee SJ; Hong S; Kim IH; Kang S
    Oncogene; 2008 Mar; 27(12):1716-25. PubMed ID: 17873902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.